Riboflavin Corneal Crosslinking Market to Reach USD 385.0 Million by 2034 at 8.5% CAGR as Treatment Demand Expands View the complete report: https://www.24chemicalresearch.com/reports/309128/riboflavin-vitamin-b-photocrosslinker-corneal-collagen-stiffening-forecast-market The market is shaped by demand for keratoconus treatment, evolving riboflavin formulations, and the requirements of specialist ophthalmology providers. North America leads regional revenue, while regulatory approvals, reimbursement coding, and formulation suitability remain important factors influencing market development.